心肌梗死驱动单核细胞训练免疫加速动脉粥样硬化
研究在ApoE-/-小鼠及骨髓移植嵌合体中进行MI或缺血再灌注,并给予12周高脂饮食,发现MI诱导的单核细胞训练免疫可通过骨髓移植传递并加速动脉粥样硬化。机制涉及KMT5A与CNBP协同上调SYK,而siRNA抑制KMT5A或CNBP、以及6-羟基多巴胺交感神经去支配可减轻MI后动脉粥样硬化与炎症。STEMI伴晚期冠脉病变患者经典单核细胞SYK与KMT5A基因水平升高。
要点
- MI诱导的单核细胞训练免疫可经骨髓移植传递并加速动脉粥样硬化。
- KMT5A与CNBP协同上调SYK,siRNA抑制二者可减缓MI后动脉粥样硬化。
- STEMI伴晚期冠脉病变患者经典单核细胞SYK与KMT5A基因水平更高。
核心结论
- 单核细胞训练免疫在MI后加速动脉粥样硬化中起关键作用。
- 血液经典单核细胞SYK可能作为STEMI患者动脉粥样硬化进展的预测因素。
研究设计与样本
- ApoE-/-小鼠与接受骨髓移植的嵌合体小鼠经历MI或心肌缺血再灌注,随后接受12周高脂饮食。
- 对入组患者血液中的经典单核细胞进行流式细胞术分析。
主要发现
- MI与缺血再灌注小鼠在暴露于高脂饮食或oxLDL刺激后,血液单核细胞与骨髓来源巨噬细胞中SYK、KMT5A与CNBP表达升高。
- MI诱导的训练免疫可通过骨髓移植传递,加速naive受体的动脉粥样硬化。
- KMT5A将H4K20me单甲基化特异性招募至SYK基因体,并与CNBP协同反式激活SYK。
- 体内siRNA抑制KMT5A或CNBP可减缓MI后动脉粥样硬化。
- 6-羟基多巴胺交感神经去支配减少MI后动脉粥样硬化与炎症。
关键数值与推荐
- STEMI伴晚期冠脉病变患者经典单核细胞SYK与KMT5A基因水平升高。
临床怎么用
- 血液经典单核细胞SYK或可作为STEMI患者动脉粥样硬化进展的预测指标。
- 靶向KMT5A或CNBP的siRNA策略在动物模型中减缓MI后动脉粥样硬化。
- 交感神经去支配在动物模型中减少MI后动脉粥样硬化与炎症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Survivors of acute coronary syndromes face an elevated risk of recurrent atherosclerosis-related vascular events despite advanced medical treatments. The underlying causes remain unclear. This study aims to investigate whether myocardial infarction (MI)-induced trained immunity in monocytes could sustain proatherogenic traits and expedite atherosclerosis. METHODS: Apolipoprotein-E deficient (ApoE-/-) mice and adoptive bone marrow transfer chimeric mice underwent MI or myocardial ischaemia-reperfusion (IR). A subsequent 12-week high-fat diet (HFD) regimen was implemented to elucidate the mechanism behind monocyte trained immunity. In addition, classical monocytes were analysed by flow cytometry in the blood of enrolled patients. RESULTS: In MI and IR mice, blood monocytes and bone marrow-derived macrophages exhibited elevated spleen tyrosine kinase (SYK), lysine methyltransferase 5A (KMT5A), and CCHC-type zinc finger nucleic acid-binding protein (CNBP) expression upon exposure to a HFD or oxidized LDL (oxLDL) stimulation. MI-induced trained immunity was transmissible by transplantation of bone marrow to accelerate atherosclerosis in naive recipients. KMT5A specifically recruited monomethylation of Lys20 of histone H4 (H4K20me) to the gene body of SYK and synergistically transactivated SYK with CNBP. In vivo small interfering RNA (siRNA) inhibition of KMT5A or CNBP potentially slowed post-MI atherosclerosis. Sympathetic denervation with 6-hydroxydopamine reduced atherosclerosis and inflammation after MI. Classical monocytes from ST-elevation MI (STEMI) patients with advanced coronary lesions expressed higher SYK and KMT5A gene levels. CONCLUSIONS: The findings underscore the crucial role of monocyte trained immunity in accelerated atherosclerosis after MI, implying that SYK in blood classical monocytes may serve as a predictive factor for the progression of atherosclerosis in STEMI patients.
引用
- Dong, Hou, Luo, et al. Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis. Eur Heart J. 2024. PMID: 38085922. doi:10.1093/eurheartj/ehad787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。